Latanoprost Zonder Conserveermiddel Stulln (Latanoprost)

Latanoprost mimics prostaglandin F2α and binds to FP receptors in the ciliary body, enhancing uveoscleral outflow of aqueous humor. This increased drainage reduces intra‑ocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing must follow the clinician’s instructions.

The safety of latanoprost during pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the prescriber should evaluate each case individually.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and a favorable efficacy profile compared with beta‑blockers or carbonic anhydrase inhibitors. It is often preferred for its potency in lowering intra‑ocular pressure and its convenient dosing schedule, though individual response may vary.

Store the eye‑drop bottle at room temperature, below 25 °C, in its original packaging. Protect it from direct light, moisture, and extreme temperature fluctuations. Do not freeze the product, and keep the cap tightly closed when not in use.

Wash hands thoroughly, tilt the head back, and gently pull down the lower eyelid to form a small pocket. Squeeze one drop onto the ocular surface without touching the tip to the eye or surrounding tissues. Close the eye gently for a few minutes and avoid excessive blinking.

Although rare, serious adverse events may include severe eye pain, sudden loss of vision, corneal edema, uveitis, or a paradoxical increase in intra‑ocular pressure. If any of these symptoms occur, discontinue use and seek immediate ophthalmologic evaluation.

Patients with known hypersensitivity to latanoprost or any component of the formulation should avoid the product. It is also contraindicated in individuals with active ocular infections, inflammation, or those who have had recent ocular surgery unless directed by an eye specialist.